Navigation Links
Met-Pro Corporation's Fybroc Business Unit Receives Equipment Order Totaling Approximately $500,000
Date:6/12/2008

HARLEYSVILLE, Pa., June 12 /PRNewswire-FirstCall/ -- Raymond J. De Hont, Chairman and Chief Executive Officer of Met-Pro Corporation (NYSE: MPR), announced today that the Company's Fybroc business unit has received an order for approximately $500,000 in pumps. The order is expected to ship in the second and third quarters of the Company's current fiscal year ending Jan. 31, 2009.

"This is second large order Fybroc has received this year from the Eastern European market," stated De Hont. "It reinforces Fybroc's position as the leading fiberglass reinforced plastic (FRP) pump supplier to sea life aquariums around the world and is another example of Met-Pro's growing international reach. It is also another encouraging sign of the growing worldwide demand for not only Fybroc's products, but all of Met-Pro's innovative solutions as well."

This order is to supply one hundred-nine (109) corrosion resistant fiberglass centrifugal pumps for the new Florya Aquarium in Istanbul, Turkey. This aquarium facility, which is now under construction, will be the first in the country of Turkey and the largest aquarium in Eastern Europe. It will feature several sea life exhibits as well as other key attractions and will utilize Fybroc's 1500 Series horizontal pumps for seawater circulation, intake, and filtration, all of which are critical to proper management of the aquarium's sea life support systems. Fybroc was selected for this project based on its extensive experience in this field, as well as the successful installation and performance of its pumps in aquarium and marine-oriented facilities throughout the world. Because Fybroc pumps are virtually unaffected by seawater, they can be found in over 100 aquariums worldwide, including locations in Australia, the Bahamas, Barbados, the Canary Islands, China, Dubai, Europe, Grand Cayman, Hong Kong, Korea, Kuwait, Mexico, New Zealand, Taiwan, and multiple United States locations.

About Met-Pro

Met-Pro Corporation, with headquarters at 160 Cassell Road, Harleysville, Pennsylvania, was recently recognized, for the second consecutive year, as one of America's "200 Best Small Companies" by Forbes magazine. The Company was also recently named as one of the world's "Top Small to Midsize Manufacturers" by Start-It magazine for the second year in a row. Through its business units, in the United States, Canada, Europe and The People's Republic of China, a wide range of products and services are offered for industrial, commercial, municipal and residential markets worldwide. These include product recovery and pollution control technologies for purification of air and liquids; fluid handling technologies for corrosive, abrasive and high temperature liquids; Mefiag filtration technologies for harsh, corrosive liquid filtration applications; and filtration and purification technologies which include proprietary water treatment chemicals and filter products for air and liquid filtration. For more information, please visit http://www.met-pro.com.

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this news release, and other materials filed or to be filed with the Securities and Exchange Commission (as well as information included in oral or other written statements made or to be made by the Company), contain statements that are forward-looking. Such statements may relate to plans for future expansion, business development activities, capital spending, financing, the effects of regulation and competition, or anticipated sales or earnings results. Such information involves risks and uncertainties that could significantly affect results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by or on behalf of the Company. These risks and uncertainties include, but are not limited to, those relating to, the cancellation or delay of purchase orders and shipments, product development activities, computer systems implementation, dependence on existing management, the continuation of effective cost and quality control measures, retention of customers, global economic and market conditions, and changes in federal or state laws.

Met-Pro common shares are traded on the New York Stock Exchange, symbol MPR.

To obtain an Annual Report or additional information on the Company, please call 215-723-6751 and ask for the Investor Relations Department, or visit the Company's website at http://www.met-pro.com.

Contact: Investor Contact:

Gary J. Morgan,

Senior Vice President of Finance and CFO

215-723-6751

gmorgan@met-pro.com

Joseph Hassett, VP

Gregory FCA Communications

610-642-8253 extension 120

joeh@gregoryfca.com


'/>"/>
SOURCE Met-Pro Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Highlights of Economic and Business Growth in the Tampa Bay Region
2. KV Pharmaceutical Company Comments on Legal Development in Its Branded Pharmaceutical Business
3. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on Current Business and COS Certification
4. ImmunoVaccine Technologies Congratulates Dr. Ramila Philip as One of PAs Best 50 Women in Business
5. Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
6. Better business decisions with real-time data
7. DuPont Expands Animal Health Solutions Business in Asia
8. CEO Addresses Fort Worth Business Leaders About Developing Pandemic and Business Continuity Plans
9. Vermillion Announces First Quarter 2008 Financial Results and Business Progress
10. ThromboGenics N.V. - Business Update
11. MedApps Selected as Dell-NFIB 2008 Business Excellence Award Finalist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , ... January 19, 2017 ... ... advanced software solutions for pharmaceutical research and development (R&D), today announced the ... omic data analysis and interpretation for the rapidly evolving field of precision ...
(Date:1/19/2017)... , Jan. 19, 2017  ArmaGen, Inc., today ... , Ph.D., as chief executive officer, as well ... Dr. Schmidt brings to ArmaGen more than 17 years ... and development of biotherapeutics and pharmaceuticals. ... the diverse experience and skillset necessary to lead ...
(Date:1/19/2017)... , ... January 18, 2017 , ... ... tech innovators, engineers, and scientists from around the world, was today awarded the ... awards program is based entirely on merit and decided upon by a dedicated ...
(Date:1/19/2017)... NEW YORK , Jan. 18, 2017 /PRNewswire/ ... expected to reach USD 92.9 billion by 2025, ... Research, Inc. Pharmaceutical industry has been adaptive of ... functions as early as 2002. Among the services ... the forerunners. For instance, Johnson & Johnson was ...
Breaking Biology Technology:
(Date:1/12/2017)... 2017 A new report by Allied Market Research, titled, "Global ... technology market is expected to generate revenue of $10.72 billion by 2022, with an ... Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) In the year ...
(Date:1/6/2017)... 2017  SomaLogic announced today that it has ... by iCarbonX, the China -based ... Digital Health Ecosystem that can define each person,s ... biological, behavioral and psychological data, the Internet and ... SomaLogic will provide proteomics data and applications expertise ...
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
Breaking Biology News(10 mins):